Science and Research

It takes two peroxisome proliferator-activated receptors (PPAR-

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by aberrant lung epithelial phenotypes, fibroblast activation, and increased extracellular matrix deposition. Transforming growth factor-beta (TGF-

  • Boateng, E.
  • Bonilla-Martinez, R.
  • Ahlemeyer, B.
  • Garikapati, V.
  • Alam, M. R.
  • Trompak, O.
  • Oruqaj, G.
  • El-Merhie, N.
  • Seimetz, M.
  • Ruppert, C.
  • Günther, A.
  • Spengler, B.
  • Karnati, S.
  • Baumgart-Vogt, E.

Keywords

  • Humans
  • *Idiopathic Pulmonary Fibrosis/metabolism/pathology/genetics
  • *PPAR gamma/metabolism/genetics
  • *PPAR-beta/metabolism/genetics/agonists
  • Cells, Cultured
  • *PPAR delta/metabolism/genetics
  • Fibroblasts/metabolism/pathology/drug effects
  • Peroxisomes/metabolism/drug effects
  • Peroxisome Proliferator-Activated Receptors/metabolism
  • Male
  • Transforming Growth Factor beta1/metabolism
  • Female
  • Catalase
  • Collagen
  • Human lung fibroblasts
  • Idiopathic pulmonary fibrosis
  • Matrix metalloproteinases
  • Pex13
  • Ppar
  • Peroxisome
  • Tgf-β1
Publication details
DOI: 10.1186/s12931-024-02935-7
Journal: Respir Res
Pages: 345 
Number: 1
Work Type: Original
Location: UGMLC
Disease Area: DPLD
Partner / Member: JLU
Access-Number: 39313791

DZL Engagements

chevron-down